Portfolio Logic Completes Acquisition of PSA HealthCare

All outstanding shares of PSA's common stock, par value $.01 pershare (other than shares held by Portfolio Logic and its subsidiariesand shares subject to properly exercised dissenters' rights) have beenconverted into the right to receive $16.25 in cash per share withoutinterest. Accordingly, PSA's common stock will no longer trade on theNasdaq Global Market. Mellon Investor Services LLC has been appointedagent for payment of the merger consideration. Former stockholders ofPSA with inquiries regarding the payment process should contact Mellonat 1-800-777-3674.

About PSA

PSA provides comprehensive pediatric home health care servicesthrough a network of 59 branch offices in 18 states, includingsatellite offices and branch office start-ups. Through these officesPSA provides a combination of services, including pediatric privateduty nursing (PDN) and pediatric day treatment centers (PPECs).Additional information on PSA may be found on PSA's website at.

About Portfolio Logic LLC

Portfolio Logic, a Washington, D.C.-based investment firm,primarily focuses on healthcare and business services companies.Jeffrey D. Zients, Managing Partner, previously served as Chairman ofboth The Corporate Executive Board and The Advisory Board, twosuccessful business-to-business content companies serving theseindustries.

NOTE: This press release contains certain forward-lookingstatements (as such term is defined in the Private SecuritiesLitigation Reform Act of 1995). When used in this press release, thewords "may," "targets," "goal," "could," "should," "would," "believe,""feel," "expects," "confident," "anticipate," "estimate," "intend,""plan," "potential" and similar expressions may be indicative offorward-looking statements. These statements by their nature involvesubstantial risks and uncertainties, certain of which are beyond theCompany's control. The Company cautions that various factors,including the factors described hereunder and those discussed in theCompany's other filings with the Securities and Exchange Commission,as well as potential difficulties in employee retention as a result ofthe acquisition by Portfolio Logic LLC, the amount of the costs, fees,expenses and charges related to such acquisition, general economicconditions, industry trends, the Company's anticipated uses of theproceeds from the sale of its Respiratory and Pharmacy Businesses, theCompany's ability to assimilate and manage previously acquired fieldoperations, collect accounts receivable, including receivables relatedto acquired businesses and receivables under appeal, hire and retainqualified personnel and comply with and respond to billingrequirements issues, including those related to the Company's billingand collection system, nurse shortages, competitive bidding, HIPAAregulations, adverse litigation, workers' compensation losses,availability and cost of medical malpractice insurance and anypotential reduced state funding levels and nursing hours authorized byMedicaid programs, could cause actual results or outcomes to differmaterially from those expressed in any forward-looking statements ofthe Company made by or on behalf of the Company. Any forward-lookingstatement speaks only as of the date on which such statement is made,and the Company undertakes no obligation to update any forward-lookingstatement or statements to reflect events or circumstances after thedate on which such statement is made or to reflect the occurrence ofan unanticipated event. New factors emerge from time to time, and itis not possible for management to predict all of such factors.Further, management cannot assess the impact of each such factor onthe business or the extent to which any factor, or combination offactors, may cause actual results to differ materially from thosecontained in any forward-looking statements.